In line with previous work, we demonstrate that combination of rapamycin (mTOR inhibitor) and imatinib was significantly more effective than single drug alone in inhibiting proliferation and inducing apoptosis in multiple CML cell lines (Additional file 1: Figure S2). The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.